Table 1. Baseline characteristics of... | American Society of Hematology

Table 1.

Baseline characteristics of patients (n = 113)

	n (%)	Median (range)
Age, y		59 (29-66)
Albumin, g/L		42.3 (31.8-55.5)
β2-microglobulin, mg/L		2.9 (1.2-20.6)
ISS I	65 (58)*
ISS II	30 (27)*
ISS III	18 (16)*
uIFE positive	113 (100)
κ	72 (64)
λ	41 (36)
UPEP positive	87 (78)†	1 350 (10-11 400)‡
UPEP ≥200 mg per 24 h	71 (64)†
sFLC ratio abnormal	113 (100)
κ	72 (64)	400.6 (8.3-11 292)
λ	41 (36)	0.002 (0.0002-0.066)
iFLC, mg/L		1 890 (111-27 400)
iFLC ≥100 mg/L	113 (100)
Follow up, y		3.4 (0.4-4.6)

	n (%)	Median (range)
Age, y		59 (29-66)
Albumin, g/L		42.3 (31.8-55.5)
β2-microglobulin, mg/L		2.9 (1.2-20.6)
ISS I	65 (58)*
ISS II	30 (27)*
ISS III	18 (16)*
uIFE positive	113 (100)
κ	72 (64)
λ	41 (36)
UPEP positive	87 (78)†	1 350 (10-11 400)‡
UPEP ≥200 mg per 24 h	71 (64)†
sFLC ratio abnormal	113 (100)
κ	72 (64)	400.6 (8.3-11 292)
λ	41 (36)	0.002 (0.0002-0.066)
iFLC, mg/L		1 890 (111-27 400)
iFLC ≥100 mg/L	113 (100)
Follow up, y		3.4 (0.4-4.6)

ISS, International Staging System.

Percentage totaling 101% due to rounding up.

Two patients missing data.

Milligrams per 24 hours.